Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Uterine Cervical Neoplasms | 70 | 2024 | 2020 | 12.180 |
Why?
|
Papillomavirus Infections | 35 | 2024 | 1611 | 6.450 |
Why?
|
Uterine Cervical Dysplasia | 19 | 2023 | 384 | 5.860 |
Why?
|
Papillomavirus Vaccines | 17 | 2023 | 496 | 5.340 |
Why?
|
Papillomaviridae | 20 | 2023 | 1117 | 3.930 |
Why?
|
Colposcopy | 15 | 2024 | 149 | 3.660 |
Why?
|
Early Detection of Cancer | 29 | 2024 | 3196 | 2.750 |
Why?
|
Alphapapillomavirus | 8 | 2022 | 218 | 2.600 |
Why?
|
Vaginal Smears | 14 | 2023 | 499 | 2.280 |
Why?
|
Practice Guidelines as Topic | 13 | 2024 | 7389 | 1.230 |
Why?
|
Cervix Uteri | 6 | 2021 | 570 | 1.210 |
Why?
|
Mass Screening | 17 | 2023 | 5424 | 1.120 |
Why?
|
Human papillomavirus 18 | 5 | 2021 | 125 | 0.710 |
Why?
|
Human papillomavirus 16 | 5 | 2021 | 267 | 0.650 |
Why?
|
Vulvar Neoplasms | 2 | 2018 | 263 | 0.640 |
Why?
|
Vaccination | 7 | 2023 | 3370 | 0.600 |
Why?
|
Vaginal Neoplasms | 1 | 2018 | 104 | 0.590 |
Why?
|
Female | 90 | 2024 | 392148 | 0.550 |
Why?
|
Ambulatory Care Facilities | 2 | 2020 | 934 | 0.540 |
Why?
|
Dissection | 1 | 2017 | 297 | 0.520 |
Why?
|
Adenocarcinoma | 6 | 2022 | 6340 | 0.500 |
Why?
|
Fluorouracil | 1 | 2017 | 1642 | 0.410 |
Why?
|
Humans | 93 | 2024 | 760617 | 0.390 |
Why?
|
Appointments and Schedules | 1 | 2015 | 442 | 0.370 |
Why?
|
Hysterectomy | 5 | 2016 | 856 | 0.370 |
Why?
|
Referral and Consultation | 4 | 2021 | 3599 | 0.360 |
Why?
|
Laser Therapy | 1 | 2017 | 1092 | 0.360 |
Why?
|
Carcinoma in Situ | 3 | 2013 | 791 | 0.350 |
Why?
|
Pregnancy | 11 | 2023 | 29868 | 0.340 |
Why?
|
Medical History Taking | 1 | 2013 | 773 | 0.330 |
Why?
|
Medical Errors | 1 | 2017 | 1263 | 0.320 |
Why?
|
Patient Education as Topic | 1 | 2019 | 2315 | 0.320 |
Why?
|
Uterine Hemorrhage | 3 | 1995 | 240 | 0.310 |
Why?
|
Gynecologic Surgical Procedures | 3 | 2023 | 284 | 0.310 |
Why?
|
Adult | 45 | 2024 | 220969 | 0.300 |
Why?
|
Middle Aged | 42 | 2024 | 220584 | 0.290 |
Why?
|
Electrosurgery | 2 | 2021 | 51 | 0.290 |
Why?
|
Insurance Coverage | 1 | 2018 | 1937 | 0.270 |
Why?
|
Cost-Benefit Analysis | 5 | 2023 | 5491 | 0.260 |
Why?
|
Insurance, Health | 1 | 2018 | 2495 | 0.260 |
Why?
|
Precancerous Conditions | 1 | 2011 | 980 | 0.240 |
Why?
|
Massachusetts | 4 | 2018 | 8833 | 0.240 |
Why?
|
Intraoperative Complications | 2 | 2009 | 1161 | 0.220 |
Why?
|
Academic Medical Centers | 4 | 2020 | 2756 | 0.220 |
Why?
|
Retrospective Studies | 19 | 2023 | 80566 | 0.220 |
Why?
|
Young Adult | 15 | 2022 | 59179 | 0.210 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2017 | 9277 | 0.200 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2023 | 4007 | 0.200 |
Why?
|
Risk Assessment | 5 | 2022 | 23972 | 0.190 |
Why?
|
Patient Acceptance of Health Care | 1 | 2015 | 3194 | 0.190 |
Why?
|
Healthcare Disparities | 4 | 2022 | 3351 | 0.180 |
Why?
|
Prisons | 1 | 2023 | 174 | 0.180 |
Why?
|
Triage | 3 | 2022 | 983 | 0.180 |
Why?
|
DNA, Viral | 1 | 2006 | 2195 | 0.170 |
Why?
|
Vesicovaginal Fistula | 1 | 2019 | 9 | 0.170 |
Why?
|
Neoplasms | 2 | 2018 | 22131 | 0.160 |
Why?
|
Cohort Studies | 11 | 2023 | 41457 | 0.160 |
Why?
|
Aged | 21 | 2024 | 169042 | 0.160 |
Why?
|
Guideline Adherence | 3 | 2024 | 2218 | 0.160 |
Why?
|
Postpartum Period | 2 | 2023 | 1178 | 0.160 |
Why?
|
Epidermodysplasia Verruciformis | 1 | 2018 | 22 | 0.150 |
Why?
|
United States | 13 | 2024 | 72272 | 0.150 |
Why?
|
Obstetrics | 2 | 2016 | 666 | 0.150 |
Why?
|
Laparotomy | 2 | 2016 | 456 | 0.150 |
Why?
|
Vulvar Diseases | 1 | 1998 | 64 | 0.150 |
Why?
|
Nutrition Surveys | 3 | 2020 | 1723 | 0.150 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 697 | 0.150 |
Why?
|
Fasciitis, Necrotizing | 1 | 1998 | 79 | 0.150 |
Why?
|
Administration, Intravaginal | 1 | 2017 | 149 | 0.150 |
Why?
|
Genital Neoplasms, Female | 1 | 2023 | 532 | 0.150 |
Why?
|
Endometrial Hyperplasia | 2 | 1995 | 97 | 0.140 |
Why?
|
Genital Diseases, Female | 1 | 1998 | 192 | 0.140 |
Why?
|
Developing Countries | 3 | 2016 | 2867 | 0.140 |
Why?
|
Unsafe Sex | 1 | 2018 | 238 | 0.140 |
Why?
|
Endometrial Neoplasms | 3 | 1995 | 1365 | 0.130 |
Why?
|
Cesarean Section | 2 | 2016 | 1396 | 0.130 |
Why?
|
Mouth Diseases | 1 | 2018 | 241 | 0.130 |
Why?
|
Immunocompromised Host | 2 | 2018 | 858 | 0.130 |
Why?
|
Laparoscopy | 2 | 2016 | 2030 | 0.130 |
Why?
|
Menopause | 2 | 1994 | 1645 | 0.130 |
Why?
|
Health Services Administration | 1 | 2016 | 63 | 0.120 |
Why?
|
Demography | 1 | 2020 | 1643 | 0.120 |
Why?
|
Incidence | 6 | 2021 | 21337 | 0.120 |
Why?
|
Age Factors | 5 | 2018 | 18381 | 0.120 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2015 | 242 | 0.120 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2015 | 105 | 0.120 |
Why?
|
Age Distribution | 1 | 2020 | 2871 | 0.110 |
Why?
|
Morbidity | 2 | 2016 | 1750 | 0.110 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2017 | 645 | 0.110 |
Why?
|
Behavior Therapy | 1 | 2019 | 877 | 0.110 |
Why?
|
Urban Health Services | 1 | 2014 | 176 | 0.110 |
Why?
|
Adrenergic beta-Agonists | 1 | 2015 | 346 | 0.110 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2013 | 95 | 0.110 |
Why?
|
Genes, myc | 1 | 2014 | 390 | 0.110 |
Why?
|
Follow-Up Studies | 6 | 2023 | 39063 | 0.100 |
Why?
|
Clinical Competence | 2 | 2024 | 4789 | 0.100 |
Why?
|
Thromboembolism | 1 | 1999 | 991 | 0.100 |
Why?
|
Self Disclosure | 1 | 2013 | 249 | 0.100 |
Why?
|
Conization | 1 | 2011 | 17 | 0.100 |
Why?
|
Societies, Medical | 2 | 2016 | 3900 | 0.100 |
Why?
|
Endometrium | 1 | 1994 | 403 | 0.100 |
Why?
|
Brachytherapy | 1 | 2019 | 1223 | 0.100 |
Why?
|
Postoperative Complications | 4 | 2023 | 15612 | 0.100 |
Why?
|
Inpatients | 1 | 2023 | 2544 | 0.100 |
Why?
|
Rheumatic Diseases | 1 | 2018 | 649 | 0.090 |
Why?
|
Unnecessary Procedures | 1 | 2014 | 414 | 0.090 |
Why?
|
Rural Health Services | 1 | 2014 | 384 | 0.090 |
Why?
|
Proportional Hazards Models | 2 | 2022 | 12447 | 0.090 |
Why?
|
Child Abuse, Sexual | 1 | 2013 | 403 | 0.090 |
Why?
|
Hospitals, Teaching | 1 | 2015 | 1155 | 0.090 |
Why?
|
Health Expenditures | 1 | 2023 | 2361 | 0.090 |
Why?
|
Arthritis, Rheumatoid | 2 | 2016 | 3752 | 0.090 |
Why?
|
Venous Thrombosis | 1 | 1999 | 1303 | 0.080 |
Why?
|
Boston | 2 | 2020 | 9313 | 0.080 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2013 | 294 | 0.080 |
Why?
|
Markov Chains | 1 | 2013 | 965 | 0.080 |
Why?
|
Guidelines as Topic | 1 | 2015 | 1386 | 0.080 |
Why?
|
Telomerase | 1 | 2014 | 744 | 0.080 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2015 | 1117 | 0.080 |
Why?
|
Reoperation | 1 | 2019 | 4300 | 0.080 |
Why?
|
Medical Oncology | 2 | 2020 | 2317 | 0.080 |
Why?
|
Adolescent | 8 | 2022 | 88234 | 0.080 |
Why?
|
Prenatal Care | 1 | 2016 | 1140 | 0.080 |
Why?
|
World Health Organization | 1 | 2014 | 1321 | 0.080 |
Why?
|
Quality of Life | 2 | 2020 | 13347 | 0.080 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2014 | 2509 | 0.080 |
Why?
|
Photic Stimulation | 1 | 2014 | 1987 | 0.080 |
Why?
|
Professional-Patient Relations | 1 | 2013 | 724 | 0.080 |
Why?
|
Predictive Value of Tests | 5 | 2013 | 15251 | 0.070 |
Why?
|
Biopsy | 6 | 2023 | 6762 | 0.070 |
Why?
|
Antirheumatic Agents | 1 | 2016 | 1365 | 0.070 |
Why?
|
Program Evaluation | 1 | 2015 | 2486 | 0.070 |
Why?
|
Cryosurgery | 1 | 2011 | 468 | 0.070 |
Why?
|
Pregnancy Complications, Infectious | 1 | 1998 | 2149 | 0.070 |
Why?
|
Vitamin D | 1 | 2020 | 3302 | 0.070 |
Why?
|
Quality-Adjusted Life Years | 1 | 2013 | 1722 | 0.070 |
Why?
|
Risk Factors | 10 | 2018 | 74115 | 0.060 |
Why?
|
Prospective Studies | 4 | 2023 | 54360 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2019 | 7798 | 0.060 |
Why?
|
Postmenopause | 1 | 1994 | 2511 | 0.060 |
Why?
|
Palliative Care | 1 | 2020 | 3592 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2018 | 64568 | 0.060 |
Why?
|
RNA | 1 | 2014 | 2713 | 0.060 |
Why?
|
Dilatation and Curettage | 2 | 1994 | 52 | 0.060 |
Why?
|
Psychotherapy | 1 | 2013 | 1648 | 0.060 |
Why?
|
HIV Infections | 2 | 2021 | 17337 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2018 | 11116 | 0.050 |
Why?
|
Decision Support Techniques | 1 | 1993 | 1998 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2018 | 4020 | 0.050 |
Why?
|
Survival Analysis | 1 | 2015 | 10073 | 0.050 |
Why?
|
Health Resources | 1 | 2009 | 933 | 0.050 |
Why?
|
Health Services Accessibility | 2 | 2019 | 5430 | 0.050 |
Why?
|
Myocardium | 1 | 2015 | 4724 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2011 | 2821 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3879 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2020 | 58894 | 0.050 |
Why?
|
Heart | 1 | 2015 | 4403 | 0.050 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2014 | 2152 | 0.050 |
Why?
|
Male | 7 | 2024 | 360358 | 0.050 |
Why?
|
Length of Stay | 3 | 2023 | 6418 | 0.050 |
Why?
|
Anxiety | 1 | 2014 | 4570 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 3680 | 0.040 |
Why?
|
Angola | 1 | 2019 | 18 | 0.040 |
Why?
|
Primary Health Care | 1 | 2016 | 4668 | 0.040 |
Why?
|
Prognosis | 3 | 2013 | 29600 | 0.040 |
Why?
|
Pain | 1 | 2014 | 5061 | 0.040 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2014 | 2423 | 0.040 |
Why?
|
China | 2 | 2016 | 2374 | 0.040 |
Why?
|
Time Factors | 4 | 2021 | 39913 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2016 | 20988 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 7995 | 0.040 |
Why?
|
Botswana | 1 | 2021 | 1049 | 0.040 |
Why?
|
Vulva | 1 | 2018 | 84 | 0.040 |
Why?
|
Patient Preference | 2 | 2016 | 925 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13382 | 0.030 |
Why?
|
Condoms | 1 | 2018 | 330 | 0.030 |
Why?
|
Polynesia | 1 | 2016 | 14 | 0.030 |
Why?
|
Dental Care | 1 | 2019 | 285 | 0.030 |
Why?
|
Algorithms | 2 | 2014 | 14018 | 0.030 |
Why?
|
Debridement | 1 | 1998 | 493 | 0.030 |
Why?
|
Maternal Mortality | 1 | 1998 | 301 | 0.030 |
Why?
|
Rats, Zucker | 1 | 2015 | 131 | 0.030 |
Why?
|
Risk | 2 | 2005 | 9604 | 0.030 |
Why?
|
HeLa Cells | 1 | 2021 | 3087 | 0.030 |
Why?
|
Isoproterenol | 1 | 2015 | 397 | 0.030 |
Why?
|
Propionates | 1 | 2015 | 183 | 0.030 |
Why?
|
Echocardiography, Stress | 1 | 2015 | 134 | 0.030 |
Why?
|
Professional Practice | 1 | 2016 | 313 | 0.030 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5332 | 0.030 |
Why?
|
HIV | 1 | 2021 | 1579 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 3800 | 0.030 |
Why?
|
Psychotherapeutic Processes | 1 | 2013 | 51 | 0.030 |
Why?
|
Reminder Systems | 1 | 2016 | 386 | 0.030 |
Why?
|
Prevalence | 2 | 2021 | 15689 | 0.030 |
Why?
|
Obesity | 1 | 2015 | 12933 | 0.030 |
Why?
|
Treatment Failure | 1 | 2019 | 2635 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14648 | 0.030 |
Why?
|
Odds Ratio | 2 | 2014 | 9643 | 0.030 |
Why?
|
Logistic Models | 2 | 2019 | 13245 | 0.030 |
Why?
|
Pelvis | 1 | 2016 | 732 | 0.020 |
Why?
|
Signal Transduction | 1 | 2015 | 23416 | 0.020 |
Why?
|
Minority Groups | 1 | 2019 | 1202 | 0.020 |
Why?
|
Clinical Coding | 1 | 2013 | 181 | 0.020 |
Why?
|
Bronchodilator Agents | 1 | 2015 | 512 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2014 | 12043 | 0.020 |
Why?
|
Psychological Tests | 1 | 2013 | 639 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2023 | 20074 | 0.020 |
Why?
|
Lymph Node Excision | 1 | 2016 | 1269 | 0.020 |
Why?
|
Office Visits | 1 | 1994 | 593 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5239 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6474 | 0.020 |
Why?
|
Robotics | 1 | 2016 | 816 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 2015 | 1515 | 0.020 |
Why?
|
Quinolines | 1 | 2015 | 764 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2013 | 11069 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2016 | 2423 | 0.020 |
Why?
|
Rats | 2 | 2015 | 23717 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2014 | 2925 | 0.020 |
Why?
|
Health Services Research | 1 | 2016 | 1808 | 0.020 |
Why?
|
Terminal Care | 1 | 2020 | 1755 | 0.020 |
Why?
|
Sexually Transmitted Diseases | 1 | 2014 | 661 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2016 | 3593 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2606 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3410 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2016 | 1167 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2014 | 22148 | 0.020 |
Why?
|
Life Expectancy | 1 | 1993 | 1239 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10548 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2016 | 1418 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2015 | 1667 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2018 | 26049 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2016 | 3461 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5034 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10199 | 0.010 |
Why?
|
Anticoagulants | 1 | 1999 | 4785 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2013 | 6016 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8207 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8645 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1998 | 12966 | 0.010 |
Why?
|
Self Report | 1 | 2014 | 3723 | 0.010 |
Why?
|
Health Behavior | 1 | 2014 | 2643 | 0.010 |
Why?
|
Calcium | 1 | 2015 | 5717 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12719 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14591 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2014 | 4174 | 0.010 |
Why?
|
Hospitalization | 1 | 1998 | 10704 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2012 | 7583 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 7960 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2013 | 4803 | 0.010 |
Why?
|
Aging | 1 | 2015 | 8699 | 0.010 |
Why?
|
Animals | 2 | 2015 | 168201 | 0.010 |
Why?
|
Child | 1 | 2013 | 80079 | 0.000 |
Why?
|